Skip to main content

Advertisement

ADVERTISEMENT

Poster CS-004

A New Treatment Modality to Expedite Healing in the Case of a Transmetatarsal Breakdown

Jean W Gillon, MD

Alton Johnson, DPM, CWSP – Clinical Assistant Professor, Department of Internal Medicine, University of Michigan

Symposium on Advanced Wound Care Spring Spring 2022

The patient is a 65 year old Polynesian male with a medical history of hypertension, dialysis dependent renal failure, coronary artery bypass, status post left below knee amputation and a recent right failing transmetatarsal amputation. The patient underwent a closed right transmetatarsal amputation for gangrenous toes in May 2020 by a podiatrist. This slowly began to fail and by November had extensive dry and wet gangrene present. The podiatrist referred the patient to a vascular surgeon who told him he would need a right below knee amputation (BKA). The family sought a second opinion.

He was seen by a second vascular surgeon December 29, 2020 and was found to have extensive wet and dry gangrene present; however, by Doppler he had biphasic signals in both the dorsalis pedis and posterior tibial arteries. He was advised that there might be a chance to salvage the transmetatarsal amputation. A regime of weekly debridements and daily wet to dry dressing changes produced steady improvement. One month later the wound appeared salvageable with only some peripheral dry gangrene and a 40% base of granulation tissue. In February the surgeon initiated treatment with AC5®Advanced Wound System (AC5) with the hope that it might shorten the healing time and expedite the growth of a base of granulation tissue. After 3 weekly treatments with AC5 as well as weekly debridements and daily dressing changes, there was a remarkable improvement in the wound.

The wound shrank from 4 x 3 inches to 3 x 1.5 inches with a near 90% coverage of healthy pink granulation tissue. The serosanguinous drainage initially present also nearly abated and peripheral dry gangrene considerably diminished. Wound healing of transmetatarsal breakdown was significantly expedited with a new wound management system, AC5. AC5 has been shown in prior clinical experience to promote healing of chronic, recalcitrant wounds, to provide a barrier of protection from biocontamination, to help reduce inflammation, and to provide a network for adhesion, migration, and proliferation of cytotypes fundamental to the cascade of wound healing.

References

Pollard J, Hamilton GA, Rush SM, Ford LA, Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases, J Foot Ankle Surg, 2006;45(2):91–97.Iosue H, Rosenblum B, Transmetatarsal Amputation: Predictors of success and failure, Podiatry Today, 2017;30(8):42-47.McCallum R, Tagoe M, Transmetatarsal Amputation: A case series and review of the literature, J Aging Res. 2012;2012:6, 797218, https://doi.org/10.1155/2012/797218.Kapp D, Pfendler L, D’Oro L, Wolcott R. Early clinical performance of an adaptive self-assembling barrier scaffold in nonhealing chronic wounds: a review of six cases. Wounds. 2022;34(1):20-30. doi:10.25270/wnds/2022.2030.

Trademark

AC5(R) Advanced Wound System, Arch Therapeutics, Inc.

Advertisement

Advertisement

Advertisement